Pegaptanib: all 33 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Extension Study to Gather Data on Effect of Macugen on the Corneal EndotheliumCompletedNCT01573572Phase 4Results posted
- Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) StudyCompletedNCT01486238Phase 4Results posted
- Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular EdemaCompletedNCT01189461Phase 3Results posted
- A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular EdemaCompletedNCT01100307Phase 3Results posted
- Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular EdemaCompletedNCT00790803Not applicableResults posted
- A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.CompletedNCT00605280Phase 2/3Results posted
- Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein OcclusionCompletedNCT00406107Phase 4Results posted
- An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMDTerminatedNCT00327470Phase 4Results posted
- Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration LesionsCompletedNCT00324116Phase 4Results posted
- Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular DegenerationCompletedNCT00239928Phase 2Results posted
- Cohort Study of the Clinical Course of Macular Diseases in KagawaStatus unknownNCT02321267Phase 4
- A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic RetinopathyWithdrawnNCT01589718Phase 3
- A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic RetinopathyCompletedNCT01487070Phase 1
- Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)Status unknownNCT01486771Phase 4
- Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic MyopiaWithdrawnNCT01218230Not applicable
- Subretinal Macugen® for Neovascular Age-Related Macular DegenerationStatus unknownNCT00788177Phase 3
- MAAM Study: Avastin and Macugen Versus Avastin Versus MacugenCompletedNCT00531336Phase 2
- Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)CompletedNCT00446381Not applicable
- The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular EdemaTerminatedNCT00358423Phase 1/2
- A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMDStatus unknownNCT00354445Phase 4
- Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in DiabeticsTerminatedNCT00346983Phase 1/2
- A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.CompletedNCT00321997Phase 2/3
- A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)TerminatedNCT00312351Phase 4
- Macugen for HistoplasmosisTerminatedNCT00272766Not applicable
- Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)CompletedNCT00215670Phase 2/3
- Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)CompletedNCT00150202Phase 3
- Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)TerminatedNCT00134667Phase 4
- Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)CompletedNCT00088283Phase 2
- Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)CompletedNCT00088192Not applicable
- Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)CompletedNCT00087763Phase 2
- EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau SyndromeCompletedNCT00056199Phase 1
- Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the MaculaCompletedNCT00040313Phase 2
- Phase II/III Study of Anti-VEGF in Neovascular AMDCompletedNCT00021736Phase 2/3